Important pathogenic alterations within established cancers are acquired du
ring the premalignant stage. These genetic alterations can be grouped into
specific neoplastic pathways that differ within and between anatomical site
s. By understanding the mechanisms that determine the initiation and progre
ssion of each pathway, it will be possible to develop novel approaches to t
he diagnosis, prevention and treatment of cancer. This chapter outlines the
principles underlying the molecular characterization of pre-malignant lesi
ons, taking colorectal neoplasia as the main model.